CA2432525C - Streptococcus pyogenes antigens and corresponding dna fragments - Google Patents

Streptococcus pyogenes antigens and corresponding dna fragments Download PDF

Info

Publication number
CA2432525C
CA2432525C CA2432525A CA2432525A CA2432525C CA 2432525 C CA2432525 C CA 2432525C CA 2432525 A CA2432525 A CA 2432525A CA 2432525 A CA2432525 A CA 2432525A CA 2432525 C CA2432525 C CA 2432525C
Authority
CA
Canada
Prior art keywords
polypeptide
ala
gly
lys
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2432525A
Other languages
English (en)
French (fr)
Other versions
CA2432525A1 (en
Inventor
Denis Martin
Josee Hamel
Bernard R. Brodeur
Stephane Rioux
Patrick Rheault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2789252A priority Critical patent/CA2789252C/en
Publication of CA2432525A1 publication Critical patent/CA2432525A1/en
Application granted granted Critical
Publication of CA2432525C publication Critical patent/CA2432525C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
CA2432525A 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments Expired - Fee Related CA2432525C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2789252A CA2789252C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21
US60/256,940 2000-12-21
PCT/CA2001/001853 WO2002050107A2 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2789252A Division CA2789252C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Publications (2)

Publication Number Publication Date
CA2432525A1 CA2432525A1 (en) 2002-06-27
CA2432525C true CA2432525C (en) 2012-11-27

Family

ID=22974225

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2432525A Expired - Fee Related CA2432525C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments
CA2789252A Expired - Fee Related CA2789252C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2789252A Expired - Fee Related CA2789252C (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Country Status (12)

Country Link
US (5) US7595057B2 (https=)
EP (1) EP1343895B1 (https=)
JP (1) JP4080876B2 (https=)
AT (1) ATE398677T1 (https=)
AU (2) AU2002216863B8 (https=)
BE (1) BE2021C506I2 (https=)
BR (1) BR0116704A (https=)
CA (2) CA2432525C (https=)
DE (1) DE60134494D1 (https=)
ES (1) ES2307564T3 (https=)
FR (1) FR21C1005I2 (https=)
WO (1) WO2002050107A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
WO2005017093A2 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
EP4687953A2 (en) * 2023-03-29 2026-02-11 Cyrus Biotechnology, Inc. Ides variant proteins and methods of using the same

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
CA2321106C (en) * 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
GB9807890D0 (en) * 1998-04-09 1998-06-10 Actinova Ltd Peptides
WO2000006736A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
ATE361365T1 (de) 1998-07-27 2007-05-15 Sanofi Pasteur Ltd Streptococcus pneumoniae proteine und nukleinsäuren
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) * 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
JP4718099B2 (ja) * 2000-07-06 2011-07-06 アイディー バイオメディカル コーポレイション ストレプトコッカス・パイオジェンス抗原
JP4102186B2 (ja) * 2000-10-13 2008-06-18 アイディー バイオメディカル コーポレイション グループｂストレプトコッカスのｂｖｈ−ａ２及びｂｖｈ−ａ３抗原
CA2881568C (en) * 2000-10-27 2019-09-24 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from streptococcus groups a & b
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
BRPI0207447B1 (pt) * 2001-02-21 2015-09-22 Id Biomedical Corp polipeptídeo recombinante isolado, seu uso e processo de produção, vetor de expressão, célula hospedeira microbiana transgênica, composição farmacêutica, uso da dita composição, métodos de detecção e kit
BR0208874A (pt) * 2001-04-13 2004-06-22 Wyeth Corp Proteìnas superficiais de streptococcus pyogenes
BR0210875A (pt) * 2001-07-06 2004-06-22 Shire Biochem Inc Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
EP1456231A2 (en) * 2001-12-20 2004-09-15 Shire Biochem Inc. Streptococcus antigens
AU2003246495A1 (en) * 2002-07-15 2004-02-02 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
WO2005017093A2 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
US7838010B2 (en) * 2004-10-08 2010-11-23 Novartis Vaccines And Diagnostics S.R.L. Immunogenic and therapeutic compositions for Streptococcus pyogenes
PL1901773T3 (pl) * 2005-06-09 2012-09-28 Hansa Medical Ab Zastosowanie proteinazy IDES (Z S. Pyogenes) do leczenia chorób autoimmunologicznych oraz odrzutów przeszczepu
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
DK2190984T3 (da) * 2007-09-14 2013-12-02 Genovis Ab Fremgangsmåder og kits til oprensning og påvisning af glycosyleret IgG
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Also Published As

Publication number Publication date
JP2004524014A (ja) 2004-08-12
US20100119507A1 (en) 2010-05-13
FR21C1005I1 (https=) 2021-03-26
EP1343895A2 (en) 2003-09-17
US8821895B2 (en) 2014-09-02
US20040097706A1 (en) 2004-05-20
AU1686302A (en) 2002-07-01
US20150017684A1 (en) 2015-01-15
JP4080876B2 (ja) 2008-04-23
US20160326221A1 (en) 2016-11-10
WO2002050107A3 (en) 2003-04-10
AU2002216863B2 (en) 2008-02-28
EP1343895B1 (en) 2008-06-18
FR21C1005I2 (fr) 2022-01-14
BR0116704A (pt) 2003-12-23
US20130136760A1 (en) 2013-05-30
AU2002216863B8 (en) 2008-03-20
BE2021C506I2 (https=) 2021-05-31
CA2789252A1 (en) 2002-06-27
US7595057B2 (en) 2009-09-29
ATE398677T1 (de) 2008-07-15
US8298551B2 (en) 2012-10-30
DE60134494D1 (de) 2008-07-31
US9340586B2 (en) 2016-05-17
WO2002050107A2 (en) 2002-06-27
CA2789252C (en) 2016-11-15
ES2307564T9 (es) 2021-04-26
ES2307564T3 (es) 2008-12-01
CA2432525A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
US7811585B2 (en) Streptococcus pyogenes antigens
US7883706B2 (en) Methods for using Streptococcus pyogenes polypeptides
US20160326221A1 (en) Streptococcus pyogenes antigens and corresponding dna fragments
AU2002234455A1 (en) Streptococcus pyogenes polypeptides and corresponding DNA fragments
EP2025754A2 (en) Moraxella (Branhamella) catarrhalis antigens
EP1399563B1 (en) Moraxella (branhamella) catarrhalis antigens
AU2001272270B2 (en) Streptococcus pyogenes antigen
AU2002302236A1 (en) Moraxella(Branhamella) catarrhalis antigens
WO2004007725A1 (en) Polypeptide of streptococcus pyogenes
WO2002079475A2 (en) Streptococcus pyogenes antigens and corresponding dna fragments
AU2001272270A1 (en) Streptococcus pyogenes antigen
AU2002344869A1 (en) Moraxella (branhamella) catarrhalis antigens

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20191223